Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506357 · ClinicalTrials.gov registry record · NA
A Single Group Study to Evaluate the Effects of a Probiotic Supplement on Vaginal Health.
A NA study, sponsored by Love Wellness.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06506357: Completed NA study, sponsored by Love Wellness.
NCT06506357 is a NA study that has completed, run by Love Wellness. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06506357, a NA study, has completed, sponsored by Love Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This virtual single-group clinical trial aims to evaluate the effects of the Good Girl Probiotics supplement on vaginal health. Participants will take one capsule of the probiotic supplement daily for eight weeks. They will complete questionnaires at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8 to assess changes in vaginal pH, vaginal health, and urinary tract health.
Primary Outcome
Assessment of vaginal and urinary tract health and balance through questionnaires completed by participants at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8.
Interventions
- DIETARY_SUPPLEMENT Good Girl Probiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2024-06-24 |
| Phase | NA |
What the finished NCT06506357 record still lists
NCT06506357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Good Girl Probiotics is the first listed.
NCT06506357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06506357 about?
NCT06506357 is a clinical study titled "A Single Group Study to Evaluate the Effects of a Probiotic Supplement on Vaginal Health.". This virtual single-group clinical trial aims to evaluate the effects of the Good Girl Probiotics supplement on vaginal health. Participants will take one capsule of the probiotic supplement daily for eight weeks. They will complete questionnaires at Baseline, after the first dose, and at the end of...
What is the current status of trial NCT06506357?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-04-24. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT06506357?
The interventions under investigation include: Good Girl Probiotics (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06506357?
This trial is sponsored by Love Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06506357's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI